Skip to content

Using e-Technologies to Maximize Physical Activity After Cancer Treatment

Using e-Technologies to Maximize Physical Activity After Cancer Treatment: The eMPACT Trial

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07535918
Enrollment
750
Registered
2026-04-17
Start date
2026-10-01
Completion date
2028-05-01
Last updated
2026-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Brief summary

The Cancer Exercise app (CEA) is designed to promote physical activity among cancer survivors. The proposed randomized controlled clinical trial will investigate, in adults who have completed cancer treatment, the effects of a 12-week home-based exercise program, delivered using CEA, on physical activity levels. Participants will be randomized into one of two groups: (1) CEA or (2) Usual Care.

Interventions

BEHAVIORALCancer Exercise App

Use of Cancer Exercise app to increase physical activity levels among cancer survivors.

Sponsors

University of Florida
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* 18 to 85 years of age * Diagnosed with stage I-III cancer * Completed all primary cancer treatments (e.g., surgery, radiation, chemotherapy) at least 6 months prior to enrollment. Adjuvant endocrine therapy, CDK4/6 inhibitors, PARP inhibitors, immunotherapy, and bisphosphonates are allowed within 6 months of study enrolment and during study participation. * Own a smartphone with data plan or access to WiFi (Apple or Android) * Medical clearance provided or no medical clearance needed based on exercise preparticipation screening.

Exclusion criteria

* consistently engage in \>300 min/week of moderate-intensity physical activity or 150 min/week of vigorous-intensity physical activity in the past 3 months * receiving or scheduled to receive surgery or radiation during study participation * have stage IV metastatic cancer or evidence of cancer recurrence * have multiple myeloma * have received bone marrow or hematopoietic stem cell transplant within past year * are unable to walk without support or have severe weakness or balance problems that limit safe participation in exercise * contraindications to participate in unsupervised exercise * are pregnant * unable to read, speak and understand English

Design outcomes

Primary

MeasureTime frameDescription
Change in moderate to vigorous physical activity from pre- to post-interventionBaseline and following the 12-week interventionModerate to vigorous physical activity will be assessed using the International Physical Activity Questionnaire, a well-validated and reproducible questionnaire for use among cancer survivors

Contacts

CONTACTResearch Coordinator
eMPACT@hhp.ufl.edu(352) 294-1742
PRINCIPAL_INVESTIGATORDemetra Christou, PhD

University of Florida

PRINCIPAL_INVESTIGATORDanielle Jake-Schoffman, PhD

University of Florida

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 28, 2026